Fresenius Medical Care AG & Co. KGAA (FMS)
Fresenius Medical Care AG & Co. KGAA Expenses TTM: 11.76B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
FMS Expenses TTM Rankings
| Overall | 93rd percentile | 299 of 4324 |
| Sector | 95th percentile | 21 of 450 in Healthcare |
| Industry | 93rd percentile | 1 of 16 in Specialized Health Services |
FMS Expenses TTM Range, Past 5 Years
| Minimum | 8.681B | Jun 2007 |
| Maximum | 11.76B | Mar 2012 |
| Average | 10.30B |
About Expenses (TTM)
YCharts calculates Expense (TTM) as the sum of the last four quarters of:
Total Revenues - Net Income
Learn More
You may also be interested in these FMS related companies
FMS News
Auriga Maintains a 'Buy' on Affymax, Inc. (AFFY); Milestone Payments Drive Q1 Upside; Continue Seeing Market Opp for Omontys
May 08, 10:42AM Street Insider
May 08, 10:42AM Street Insider
Fresenius Medical Care and Celebrity Chef Aaron McCargo Jr. Offer Tips for Budget-Friendly Cooking on a Renal Diet
Mar 15, 12:58PM Business Wire
Mar 15, 12:58PM Business Wire
Think $FMS will challendge 200-EMA in not distant future. Look at yesterday's volume
about 76 days ago by britepathos
about 76 days ago by britepathos
$WPRT No Nat gas act, no subsidies, no profit, not this year. Graphite stocks for electric car batteries are the hot ticket now $NGC, $FMS
about 77 days ago by kel4003
about 77 days ago by kel4003
Fresenius Medical Care Offers Five Tips to Help Slow the Progression of Kidney Disease
Feb 29, 10:30AM Business Wire
Feb 29, 10:30AM Business Wire
Dividends of Death: Yields of 3.19% to 5.59% on Your Neighbor’s Unhealthy Lifestyle http://stks.co/2OgN $PEP $MO $HI $FMS $DVA $CAG $ABV
about 105 days ago by ycharts
about 105 days ago by ycharts
Aetna and Fresenius Medical Care Begin Chronic Kidney Disease Management Program
Feb 10, 11:03AM Business Wire
Feb 10, 11:03AM Business Wire
Fresenius Medical Care Salutes Patients Who Prioritize Fitness and Health
Jan 19, 9:00AM Business Wire
Jan 19, 9:00AM Business Wire
Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
Jan 09, 3:00PM PR Newswire
Jan 09, 3:00PM PR Newswire
Fresenius Medical Care's Centenarian Patients Are a Testament to Success of Dialysis Treatments
Dec 23, 2:45PM Business Wire
Dec 23, 2:45PM Business Wire
U.S. Medical Testing Laboratory Earns Second Global Accreditation for Quality and Competency
Dec 06, 9:00AM Business Wire
Dec 06, 9:00AM Business Wire
Fresenius Medical Care Launches Healthy Lifestyle Initiative and Partnership with Celebrity Chef Aaron McCargo Jr.
Nov 30, 9:33AM Business Wire
Nov 30, 9:33AM Business Wire
Fresenius Medical names Franklin W. Maddux, M.D., as Chief Medical Officer
Nov 16, 11:32AM FlyOnTheWall
Nov 16, 11:32AM FlyOnTheWall
$FMS http://chart.ly/cu5f2do Retested prior breakout from cup pattern, setting up for new highs, strong sector
about 421 days ago by ToddinFL
about 421 days ago by ToddinFL
$FMS http://chart.ly/2mhfmbe Fresenius Medical Probing New Highs - Breaking Out
about 642 days ago by OptionRadar
about 642 days ago by OptionRadar
$FMS - Fresenius Medical Cup and Handle Watch into ESRD Bundled Pricing Release - http://chart.ly/2c973h
about 691 days ago by OptionRadar
about 691 days ago by OptionRadar
wow, i pitched them 2 days ago.....RT @djacome dialysis plays case u forgot $DVA $DCAI $FMS
about 776 days ago by djacome
about 776 days ago by djacome
In NEJM, FDA concerned w/kidney patient anti-anemia (epo) drug use, will convene advisory committee. $AMGN $DVA $FMS
about 873 days ago by HEALTH_NOTES
about 873 days ago by HEALTH_NOTES
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| FMS | 68.11 | +1.24 | +1.85% | 20.07B |
| EXLP | 20.60 | -0.03 | -0.15% | 861.92M |
| EXL | 11.54 | -0.04 | -0.35% | 388.16M |
| EXK | 9.01 | +0.06 | +0.67% | 785.00M |
| EXH | 12.17 | +0.55 | +4.73% | 746.82M |
| EXFO | 6.18 | +0.09 | +1.48% | 175.70M |
| EXEL | 4.51 | -0.10 | -2.17% | 684.22M |
| EXE | 3.58 | +0.04 | +1.27% | 37.70M |
| EXC | 36.76 | -0.14 | -0.38% | 31.42B |
| EXBD | 38.13 | +0.24 | +0.63% | 1.262B |
